These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 29051379)

  • 1. Ectopic colonization of oral bacteria in the intestine drives T
    Atarashi K; Suda W; Luo C; Kawaguchi T; Motoo I; Narushima S; Kiguchi Y; Yasuma K; Watanabe E; Tanoue T; Thaiss CA; Sato M; Toyooka K; Said HS; Yamagami H; Rice SA; Gevers D; Johnson RC; Segre JA; Chen K; Kolls JK; Elinav E; Morita H; Xavier RJ; Hattori M; Honda K
    Science; 2017 Oct; 358(6361):359-365. PubMed ID: 29051379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
    Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intestinal immune response is regulated by gut microbe].
    Tanemoto S; Sujino T; Kanai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiota and inflammatory bowel disease.
    Matsuoka K; Kanai T
    Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota dysbiosis in select human cancers: Evidence of association and causality.
    Chen J; Domingue JC; Sears CL
    Semin Immunol; 2017 Aug; 32():25-34. PubMed ID: 28822617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction between humans and intestinal bacteria as a determinant for intestinal health : intestinal microbiome and inflammatory bowel diseases].
    Haller D; Hörmannsperger G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):159-65. PubMed ID: 25566836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host.
    Sokol H; Seksik P
    Curr Opin Gastroenterol; 2010 Jul; 26(4):327-31. PubMed ID: 20445446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klebsiella michiganensis transmission enhances resistance to Enterobacteriaceae gut invasion by nutrition competition.
    Oliveira RA; Ng KM; Correia MB; Cabral V; Shi H; Sonnenburg JL; Huang KC; Xavier KB
    Nat Microbiol; 2020 Apr; 5(4):630-641. PubMed ID: 31959968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation.
    Clavel T; Haller D
    Curr Issues Intest Microbiol; 2007 Sep; 8(2):25-43. PubMed ID: 17542334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice.
    Hrncir T; Stepankova R; Kozakova H; Hudcovic T; Tlaskalova-Hogenova H
    BMC Immunol; 2008 Nov; 9():65. PubMed ID: 18990206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with intestinal microbiota-derived Staphylococcus aureus and Escherichia coli reduces bacteria-specific recolonization of the intestinal tract.
    Garfias-López JA; Castro-Escarpuli G; Cárdenas PE; Moreno-Altamirano MMB; Padierna-Olivos J; Sánchez-García FJ
    Immunol Lett; 2018 Apr; 196():149-154. PubMed ID: 29486232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oral bacteria in inflammatory bowel disease.
    Read E; Curtis MA; Neves JF
    Nat Rev Gastroenterol Hepatol; 2021 Oct; 18(10):731-742. PubMed ID: 34400822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron?
    Buret AG; Motta JP; Allain T; Ferraz J; Wallace JL
    J Biomed Sci; 2019 Jan; 26(1):1. PubMed ID: 30602371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
    Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional modulation of intestinal innate defense/inflammation genes by preterm infant microbiota in a humanized gnotobiotic mouse model.
    Lu L; Yu Y; Guo Y; Wang Y; Chang EB; Claud EC
    PLoS One; 2015; 10(4):e0124504. PubMed ID: 25928420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory disease caused by intestinal pathobionts.
    Zechner EL
    Curr Opin Microbiol; 2017 Feb; 35():64-69. PubMed ID: 28189956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.